Advanced Imaging and Receipt of Guideline Concordant Care in Women with Early Stage Breast Cancer

Elizabeth Trice Loggers, Diana S.M. Buist, Laura S. Gold, Steven Zeliadt, Rachel Hunter Merrill, Ruth Etzioni, Scott D. Ramsey, Sean D. Sullivan, Larry Kessler

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Objective. It is unknown whether advanced imaging (AI) is associated with higher quality breast cancer (BC) care. Materials and Methods. Claims and Surveillance Epidemiology and End Results data were linked for women diagnosed with incident stage I-III BC between 2002 and 2008 in western Washington State. We examined receipt of preoperative breast magnetic resonance imaging (MRI) or AI (defined as computed tomography [CT]/positron emission tomography [PET]/PET/CT) versus mammogram and/or ultrasound (M-US) alone and receipt of guideline concordant care (GCC) using multivariable logistic regression. Results. Of 5247 women, 67% received M-US, 23% MRI, 8% CT, and 3% PET/PET-CT. In 2002, 5% received MRI and 5% AI compared to 45% and 12%, respectively, in 2008. 79% received GCC, but GCC declined over time and was associated with younger age, urban residence, less comorbidity, shorter time from diagnosis to surgery, and earlier year of diagnosis. Breast MRI was associated with GCC for lumpectomy plus radiation therapy (RT) (OR 1.55, 95% CI 1.08-2.26, and p = 0.02) and AI was associated with GCC for adjuvant chemotherapy for estrogen-receptor positive (ER+) BC (OR 1.74, 95% CI 1.17-2.59, and p = 0.01). Conclusion. GCC was associated with prior receipt of breast MRI and AI for lumpectomy plus RT and adjuvant chemotherapy for ER+ BC, respectively.

Original languageEnglish (US)
Article number2182985
JournalInternational Journal of Breast Cancer
Volume2016
DOIs
StatePublished - Jan 1 2016
Externally publishedYes

Fingerprint

Guidelines
Breast Neoplasms
Magnetic Resonance Imaging
Breast
Segmental Mastectomy
Adjuvant Chemotherapy
Radiotherapy
Estrogen Receptors
Comorbidity
Early Diagnosis
Epidemiology
Logistic Models
Positron Emission Tomography Computed Tomography

ASJC Scopus subject areas

  • Oncology
  • Pharmacology (medical)
  • Cancer Research

Cite this

Loggers, E. T., Buist, D. S. M., Gold, L. S., Zeliadt, S., Hunter Merrill, R., Etzioni, R., ... Kessler, L. (2016). Advanced Imaging and Receipt of Guideline Concordant Care in Women with Early Stage Breast Cancer. International Journal of Breast Cancer, 2016, [2182985]. https://doi.org/10.1155/2016/2182985

Advanced Imaging and Receipt of Guideline Concordant Care in Women with Early Stage Breast Cancer. / Loggers, Elizabeth Trice; Buist, Diana S.M.; Gold, Laura S.; Zeliadt, Steven; Hunter Merrill, Rachel; Etzioni, Ruth; Ramsey, Scott D.; Sullivan, Sean D.; Kessler, Larry.

In: International Journal of Breast Cancer, Vol. 2016, 2182985, 01.01.2016.

Research output: Contribution to journalArticle

Loggers, ET, Buist, DSM, Gold, LS, Zeliadt, S, Hunter Merrill, R, Etzioni, R, Ramsey, SD, Sullivan, SD & Kessler, L 2016, 'Advanced Imaging and Receipt of Guideline Concordant Care in Women with Early Stage Breast Cancer', International Journal of Breast Cancer, vol. 2016, 2182985. https://doi.org/10.1155/2016/2182985
Loggers, Elizabeth Trice ; Buist, Diana S.M. ; Gold, Laura S. ; Zeliadt, Steven ; Hunter Merrill, Rachel ; Etzioni, Ruth ; Ramsey, Scott D. ; Sullivan, Sean D. ; Kessler, Larry. / Advanced Imaging and Receipt of Guideline Concordant Care in Women with Early Stage Breast Cancer. In: International Journal of Breast Cancer. 2016 ; Vol. 2016.
@article{029b8b130a9c4ee88703b7dedb97607d,
title = "Advanced Imaging and Receipt of Guideline Concordant Care in Women with Early Stage Breast Cancer",
abstract = "Objective. It is unknown whether advanced imaging (AI) is associated with higher quality breast cancer (BC) care. Materials and Methods. Claims and Surveillance Epidemiology and End Results data were linked for women diagnosed with incident stage I-III BC between 2002 and 2008 in western Washington State. We examined receipt of preoperative breast magnetic resonance imaging (MRI) or AI (defined as computed tomography [CT]/positron emission tomography [PET]/PET/CT) versus mammogram and/or ultrasound (M-US) alone and receipt of guideline concordant care (GCC) using multivariable logistic regression. Results. Of 5247 women, 67{\%} received M-US, 23{\%} MRI, 8{\%} CT, and 3{\%} PET/PET-CT. In 2002, 5{\%} received MRI and 5{\%} AI compared to 45{\%} and 12{\%}, respectively, in 2008. 79{\%} received GCC, but GCC declined over time and was associated with younger age, urban residence, less comorbidity, shorter time from diagnosis to surgery, and earlier year of diagnosis. Breast MRI was associated with GCC for lumpectomy plus radiation therapy (RT) (OR 1.55, 95{\%} CI 1.08-2.26, and p = 0.02) and AI was associated with GCC for adjuvant chemotherapy for estrogen-receptor positive (ER+) BC (OR 1.74, 95{\%} CI 1.17-2.59, and p = 0.01). Conclusion. GCC was associated with prior receipt of breast MRI and AI for lumpectomy plus RT and adjuvant chemotherapy for ER+ BC, respectively.",
author = "Loggers, {Elizabeth Trice} and Buist, {Diana S.M.} and Gold, {Laura S.} and Steven Zeliadt and {Hunter Merrill}, Rachel and Ruth Etzioni and Ramsey, {Scott D.} and Sullivan, {Sean D.} and Larry Kessler",
year = "2016",
month = "1",
day = "1",
doi = "10.1155/2016/2182985",
language = "English (US)",
volume = "2016",
journal = "International Journal of Breast Cancer",
issn = "2090-3170",
publisher = "Hindawi Publishing Corporation",

}

TY - JOUR

T1 - Advanced Imaging and Receipt of Guideline Concordant Care in Women with Early Stage Breast Cancer

AU - Loggers, Elizabeth Trice

AU - Buist, Diana S.M.

AU - Gold, Laura S.

AU - Zeliadt, Steven

AU - Hunter Merrill, Rachel

AU - Etzioni, Ruth

AU - Ramsey, Scott D.

AU - Sullivan, Sean D.

AU - Kessler, Larry

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Objective. It is unknown whether advanced imaging (AI) is associated with higher quality breast cancer (BC) care. Materials and Methods. Claims and Surveillance Epidemiology and End Results data were linked for women diagnosed with incident stage I-III BC between 2002 and 2008 in western Washington State. We examined receipt of preoperative breast magnetic resonance imaging (MRI) or AI (defined as computed tomography [CT]/positron emission tomography [PET]/PET/CT) versus mammogram and/or ultrasound (M-US) alone and receipt of guideline concordant care (GCC) using multivariable logistic regression. Results. Of 5247 women, 67% received M-US, 23% MRI, 8% CT, and 3% PET/PET-CT. In 2002, 5% received MRI and 5% AI compared to 45% and 12%, respectively, in 2008. 79% received GCC, but GCC declined over time and was associated with younger age, urban residence, less comorbidity, shorter time from diagnosis to surgery, and earlier year of diagnosis. Breast MRI was associated with GCC for lumpectomy plus radiation therapy (RT) (OR 1.55, 95% CI 1.08-2.26, and p = 0.02) and AI was associated with GCC for adjuvant chemotherapy for estrogen-receptor positive (ER+) BC (OR 1.74, 95% CI 1.17-2.59, and p = 0.01). Conclusion. GCC was associated with prior receipt of breast MRI and AI for lumpectomy plus RT and adjuvant chemotherapy for ER+ BC, respectively.

AB - Objective. It is unknown whether advanced imaging (AI) is associated with higher quality breast cancer (BC) care. Materials and Methods. Claims and Surveillance Epidemiology and End Results data were linked for women diagnosed with incident stage I-III BC between 2002 and 2008 in western Washington State. We examined receipt of preoperative breast magnetic resonance imaging (MRI) or AI (defined as computed tomography [CT]/positron emission tomography [PET]/PET/CT) versus mammogram and/or ultrasound (M-US) alone and receipt of guideline concordant care (GCC) using multivariable logistic regression. Results. Of 5247 women, 67% received M-US, 23% MRI, 8% CT, and 3% PET/PET-CT. In 2002, 5% received MRI and 5% AI compared to 45% and 12%, respectively, in 2008. 79% received GCC, but GCC declined over time and was associated with younger age, urban residence, less comorbidity, shorter time from diagnosis to surgery, and earlier year of diagnosis. Breast MRI was associated with GCC for lumpectomy plus radiation therapy (RT) (OR 1.55, 95% CI 1.08-2.26, and p = 0.02) and AI was associated with GCC for adjuvant chemotherapy for estrogen-receptor positive (ER+) BC (OR 1.74, 95% CI 1.17-2.59, and p = 0.01). Conclusion. GCC was associated with prior receipt of breast MRI and AI for lumpectomy plus RT and adjuvant chemotherapy for ER+ BC, respectively.

UR - http://www.scopus.com/inward/record.url?scp=85006219576&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85006219576&partnerID=8YFLogxK

U2 - 10.1155/2016/2182985

DO - 10.1155/2016/2182985

M3 - Article

VL - 2016

JO - International Journal of Breast Cancer

JF - International Journal of Breast Cancer

SN - 2090-3170

M1 - 2182985

ER -